Companies: 10,795·Total market cap: $144.5T
Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals Inc.

FENCNASDAQHealthcare● Active
$8.90
+$0.20(+2.30%)
Market Cap$254362223
P/E Ratio
52W High$10.45
52W Low$5.65
Overview

Fennec Pharmaceuticals Inc. (FENC) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

fenc · stock forecast · 7 analysts (3M) · FMP · updated Jun 9, 2026

Analyst Rating & Consensus

Based on 7 Wall Street analysts in the past 3 months

SellBuy

Buy

7 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
7
Hold
0
Sell
0
Strong Sell
0
Total: 7 · Buy rate: 100.0%

12-Month Price Target

High

$18.00

Consensus

$17.00

+91.0% upside

Low

$16.00

Median: $17 · Last Close: $8.90

The Fennec Pharmaceuticals Inc. (FENC) analyst consensus is Buy, based on ratings from 7 Wall Street analysts over the past 3 months. The average 12-month FENC price target is $17.00, representing +91.0% upside from the current price of $8.90.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $17 (91.0%)

Consensus Target

$17.00

91.0% upside

High Target

$18

102.2%

Low Target

$16

79.8%

Current Price

$8.90

as of today

Based on analyst price targets, the FENC stock price prediction for the next 12 months ranges from $16 to $18. The consensus FENC price forecast of $17.00 implies 91.0% upside from the current price of $8.90.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-10$8.890.13%

1-day model range: $8.77–$9.01. Peak: $9.01 (-0.13%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$10+8.6%
2028$10+13.3%
2029$10+15.7%
2030$10+17.0%
2031+17.6%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

NEUTRAL

Based on 14 technical indicators

50%7%43%
7Buy
1Neutral
6Sell
RSI (14)35.0Neutral
MACDBULLISH

Refreshes daily from EOD close

Moving Averages · FENC · Jun 9, 2026

Simple Moving Average (SMA)
MA 5$9.18SELL
MA 10$9.54SELL
MA 20$9.22SELL
MA 50$7.58BUY
MA 100$7.71BUY
MA 200$8.02BUY
Current $FENC · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$9.12SELL
EMA 10$9.27SELL
EMA 20$9.00SELL
EMA 50$8.23BUY
EMA 100$7.93BUY
EMA 200$7.81BUY
Current $FENC · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
HC Wainwright & Co.2026-05-22
Maintains
BuyBuy
Wedbush2026-04-16
Maintains
OutperformOutperform
HC Wainwright & Co.2025-08-21
Maintains
BuyBuy
Craig-Hallum2025-08-15
Maintains
BuyBuy
HC Wainwright & Co.2025-05-20
Maintains
BuyBuy
Craig-Hallum2025-05-14
Maintains
BuyBuy
HC Wainwright & Co.2025-03-11
Maintains
BuyBuy
HC Wainwright & Co.2024-12-17
Maintains
BuyBuy
HC Wainwright & Co.2024-08-22
Maintains
BuyBuy
Craig-Hallum2024-08-14
Maintains
BuyBuy

Wall Street analysts have recently issued updated ratings on Fennec Pharmaceuticals Inc. (FENC) stock. Of the recent 32 rating actions, 1 were upgrades and 0 were downgrades. 7 analysts currently cover FENC.

Analyst Recommendation Trends

Buy ratings11
Hold ratings00
Sell ratings00

FENC analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$68M

↓ 51.1% YoY

Revenue Next Year

$103M

↑ 49.8% YoY

EPS This Year

$0.26

EPS Next Year

$1.01

↑ 284.8% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast FENC EPS of $0.26 for the current fiscal year, based on estimates from 5 analysts. The FENC revenue forecast is $68M for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The FENC stock forecast is supported by two independent data sources: analyst consensus ratings from 7 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus FENC price target is $17.00 (+91.0% upside), with an analyst consensus of Buy.

The FENC short-term stock prediction for tomorrow is $8.89 (-0.13%). The FENC stock price prediction for 2027 estimates an average of $10. The FENC stock prediction for 2030 projects a range of $9–$12.

Fennec Pharmaceuticals Inc. trades on NASDAQ under the ticker FENC. The FENC stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

FENC forecast · 8 questions

According to 7 Wall Street analysts, the average 12-month FENC price target is $17.00, with a high forecast of $18.00 and a low of $16.00. The median price target is shown in the chart above when available. This implies +91.0% potential upside from the current price of $8.90.

FENC price targetWhat is FENC price targetFENC analyst price targetFENC 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.